HER2-Positive Localized Breast Cancer with Dr Adam Brufsky
Dr Adam Brufsky from the University of Pittsburgh discusses the latest clinical data on HER2-targeted therapy for the management of HER2-positive localized breast cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayHER2LocalizedBC21).